RedHill Biopharma Ltd. (RDHL Quick QuoteRDHL - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company — as the stock is now up 72.6% in the past one-month time frame.

The company has seen no estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

RedHill currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Redhill Biopharma Ltd. Price

Redhill Biopharma Ltd. price | Redhill Biopharma Ltd. Quote

Another stock worth considering in the Medical sector is Corcept Therapeutics Incorporated (CORT Quick QuoteCORT - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>